Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients
Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if melatonin administration to end-of-life patients
is effective in preventing the development of delirium compared with those who do not receive
this treatment. Delirium is a difficult to control symptom commonly seen in patients at the
end-of-life. A person who is delirious is unable to think clearly and cannot make sense of
what is going on around him/her.